Ftse Mib
38.622,84
0,00%
DAX
22.523,60
0,00%
S&P 500
5.861,57
-1,59%
NASDAQ
18.544,42
-2,78%
Bitcoin
78.968,11
-6,77%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tonix Pharmaceuticals Holding Corporation (TNXP) Tonix Pharmaceuticals Holding Corporation (TNXP) Notizie

Tonix Pharmaceuticals Holding Corporation

TNXP
8,0965
-0,3335 (-3,96%)
28 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202500:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202500:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202500:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202513:00EDGAR2Form 8-K - Current report
18/2/202512:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202523:05EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
07/2/202514:52EDGAR2Form 8-K - Current report
07/2/202514:30GLOBETonix Pharmaceuticals Recently Announced Preliminary Full..
06/2/202514:06EDGAR2Form 8-K - Current report
06/2/202514:00GLOBETonix Pharmaceuticals Announces Positive Topline Results..
05/2/202513:00GLOBETonix Pharmaceuticals to Participate in the 2025 BIO CEO &..
04/2/202513:09EDGAR2Form 8-K - Current report
04/2/202513:00GLOBETonix Pharmaceuticals Promotes Siobhan Fogarty to Chief..
03/2/202514:05EDGAR2Form 8-K - Current report
03/2/202514:05GLOBETonix Pharmaceuticals Announces 1-for-100 Reverse Stock..
08/1/202513:39EDGAR2Form 8-K - Current report
08/1/202513:00GLOBETonix Pharmaceuticals Further Strengthens Commercial..
07/1/202513:00GLOBETonix Pharmaceuticals to Present at Two Upcoming January..
23/12/202414:05EDGAR2Form 8-K - Current report
23/12/202414:00GLOBETonix Pharmaceuticals Announces PDUFA Goal Date of August..
20/12/202422:17EDGAR2Form 8-K - Current report
20/12/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/12/202415:25APSThis Micro Cap Is Getting Bid Up Prior To Opening Bell
17/12/202414:05EDGAR2Form 8-K - Current report
17/12/202414:00GLOBETonix Pharmaceuticals Announces FDA Acceptance of the New..
06/12/202422:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/12/202413:05EDGAR2Form 8-K - Current report
03/12/202413:00GLOBETonix Pharmaceuticals Announces Expansion of Leadership Team..
26/11/202413:00GLOBETonix Pharmaceuticals to Participate in the NobleCon20..
18/11/202422:05GLOBETonix Pharmaceuticals to Present at the Winter 2024 Investor..
18/11/202413:00GLOBETonix Pharmaceuticals Presented Data and Analyses of TNX-102..
14/11/202422:42EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:05GLOBETonix Pharmaceuticals Announces Poster Presentation at the..
13/11/202415:10EDGAR2Form 8-K - Current report
13/11/202415:05GLOBETonix Pharmaceuticals Announces Peer-Reviewed Publication in..
12/11/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:05EDGAR2Form 8-K - Current report
12/11/202414:00GLOBETonix Pharmaceuticals Reports Third Quarter 2024 Financial..
08/11/202423:15EDGAR2Form 8-K - Current report
04/11/202413:30EDGAR2Form 8-K - Current report
04/11/202413:00GLOBETonix Pharmaceuticals Announces Research Agreement with..
01/11/202412:05EDGAR2Form 8-K - Current report
01/11/202412:00GLOBETonix Pharmaceuticals Presented Data on Potential Mpox..
30/10/202421:30EDGAR2Form 8-K - Current report
29/10/202413:00GLOBETonix Pharmaceuticals to Present at BIO-Europe® 2024
28/10/202422:16EDGAR2Form 8-K - Current report
25/10/202414:00GLOBETonix Pharmaceuticals to Present at the 2024 ThinkEquity..
24/10/202414:00GLOBETonix Pharmaceuticals Announces Oral Presentation at the..
17/10/202414:05EDGAR2Form 8-K - Current report
17/10/202414:00GLOBETonix Pharmaceuticals Receives First Contract Payment from..
Apertura: 8,42 Min: 8,02 Max: 8,60
Chiusura: 8,43

La tua Cronologia

NASDAQ
TNXP
Tonix Pharmaceuticals
ASX
HMX
Hammer Metals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci